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The family of ribosome-inactivating proteins (RIPs) groups all enzymes (EC.3.2.2.22) with a  
so-called RIP domain which comprises N-glycosidase activity and enables these proteins to 
catalytically inactivate ribosomes. Ever since the discovery of the first ribosome-inactivating protein, 
this group of plant toxins has received a lot of attention from researchers in various fields. Ribosome-
inactivating proteins have been studied in detail for their distribution in nature, their molecular 
structure and toxicity, and have proven valuable tools for agricultural and biomedical research. 
Despite their long history ribosome-inactivating proteins are still at the forefront of research on 
applicability of plant toxins. 
This Special Issue of Molecules intended to collect state-of-the-art original research papers and 
review articles that cover the physiological importance of ribosome-inactivating proteins as well as 
their applications. Furthermore this Special Issue was to honour Professor Emeritus Fiorenzo Stirpe 
for pioneering work related to the study of ribosome-inactivating proteins from plants and the 
preparation of immunotoxins. The papers published in this Special Issue include four review papers 
and four original research articles. 
The first review by Bolognesi et al. [1] summarizes the most important steps in the academic 
career of Prof. Stirpe and focuses on his contributions to the frontline research on ribosome-
inactivating proteins over a period of 55 years. Together with his co-workers, Prof. Stirpe identified, 
purified and characterized a large number of new plant toxins. In addition, they studied in detail the 
biological properties and mode of action of several proteins, which ultimately gave rise to the name 
“ribosome-inactivating proteins” to designate these toxic plant proteins. The ultimate aim of the 
research was the therapeutic application of ribosome-inactivating proteins as valuable tools for 
medical research, in particular the preparation of immunotoxins for cancer research. Because of his 
outstanding contribution to the field of immunotoxins and their applications in experimental 
therapy, Prof. Stirpe received several prestigious prizes. In a second review, Bolognesi et al. [2] 
provide an historical overview of ribosome-inactivating proteins from plants. The history of these 
toxins started with the early discovery of ricin and abrin at the end of the eighteenth century, their 
purification and characterization of the biological activities at biochemical level, but has since evolved 
towards a multidisciplinary research, leading to applications in agriculture and biomedicine. 
Knowledge about the mode of action of ribosome-inactivating proteins is crucial to investigate 
possible applications. In their review, Shi et al. [3] studied the structural basis for the interaction of 
ribosome-inactivating proteins with ribosomes. Although the target site of ribosome-inactivating 
proteins is a specific adenine residue in the RNA, ribosomal proteins also contribute to the catalytic 
efficiency of the enzymes. The authors suggest that the binding to these ribosomal proteins is crucial 
for the specificity of ribosome-inactivating proteins towards eukaryotic and prokaryotic ribosomes.  
The review written by Polito et al. [4], focuses on ribosome-inactivating proteins from plants and 
their use in traditional medicine. Because of their toxic properties many RIP containing plants are 
used in folk medicine worldwide, unfortunately often without scientific validation. One of the most 
promising prospects for ribosome-inactivating proteins is their use as part of immunotoxins that 
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recognize tumour cells. In view of applications as anti-cancer agents, it is important that the 
selectivity, immunogenicity, half-life and toxicity of RIP-based conjugates are investigated. Therefore 
Chooniedass et al. [5] studied the engineering and biological activity of different conjugates 
containing the plant toxin deBouganin for their interaction with a panel of breast cancer cell lines. In 
an attempt to adapt ribosome-inactivating proteins for clinical use, Sun et al. [6] investigated the 
production, identification and anti-tumour activity of mono-pegylated ribosome-inactivating 
proteins from Momordica charantia. 
Ribosome-inactivating proteins are widely distributed in flowering plants. Shang et al. [7] report 
on the occurrence of ribosome-inactivating proteins in the family Rosaceae. They retrieved multiple 
RIP sequences from the genomes of Malus domestica, Prunus persica, Prunus mume, Pyrus communis 
and Pyrus brestschneideri but not from the genomes of Fragaria vesca and Fragaria ananassa. The results 
of in silico analysis and molecular modelling revealed that the amino acids known to be important 
for the activity of ricin are highly conserved in the active site of the RIP sequences from Malus 
domestica, suggesting that these ribosome-inactivating proteins are functional proteins, as also 
inferred from data of translation inhibition experiments with recombinant ribosome-inactivating proteins 
from apple. 
Extracts from different elderberry (Sambucus nigra) tissues as well as elderberry juices are a rich 
source of lectins, ribosome-inactivating proteins and low molecular weight nutraceuticals. Jiminez et 
al. [8] report that short-time heat treatment of extracts reduced potential allergy-related risks derived 
from elderberry consumption, but did not compromise the anti-oxidant properties and free-radical 
scavenging activities. Future in vivo studies will have to address questions related to lectin 
digestibility in animals and in food matrices. 
This Special Issue provides the readers with several up-to-date overview papers and original 
research articles that highlight the state-of-the-art of research on ribosome-inactivating proteins and 
their prospects for applications. 
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